iralukast(125617-94-9)
- Name: iralukast
- Synonyms:4H-1-Benzopyran-2-carboxylicacid,7-[[9-(4-acetyl-3-hydroxy-2-propylphenoxy)-1-[hydroxy[3-(trifluoromethyl)phenyl]methyl]-2,4-nonadienyl]thio]-4-oxo-,monosodium salt, [S-[R*,S*-(E,Z)]]-; CGP 45715A; Sodium 7-[[(1S,2E,4Z)-9-(4-acetyl-3-hydroxy-2-propylphenoxy)-1-[(aR)-a-hydroxy-m-(trifluoromethyl)benzyl]-2,4-nonadienyl]thio]-4-oxo-4H-1-benzopyran-2-carboxylate
- Molecular Formula:C38H37 F3 O8 S . Na
- Molecular Weight:734.76
- CAS Registry Number:125617-94-9
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.125617-94-9 iralukast
Assay:98% Appearance:Powder Package:inquiry Storage:-20掳C Freezer Transportation:inquiry Application:Iralukast is a Leukotriene D4 receptor antagonist originated by Novartis as a a structural analogue of LTD4. It is applicated for the treatment of asthma and inflammatory effects of these leukotri...
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 145511-51-9/(3aS)-8-methyl-2,3,3a,4,5,6-hexahydro-1H-pyrazino[3,2,1-jk]carbazole hydrochloride
- 10090-37-6/1-[2-(9,10-ethanoanthracen-9(10H)-yloxy)ethyl]pyrrolidine sulfate (1:1)
- 80890-45-5/moiety reduced)
- 63867-58-3/NNDIMETHYLNNBIS2CHLOROETHYLPIPERAZINIUMDIHYDROCHLORIDE
- 4252-21-5/L-(4,5-~3~H_2_)lysine
- 37853-26-2/1-(5-nitrothiophen-3-yl)-N-(3-thiophen-2-yloxazol-5-yl)methanimine
- 76167-80-1/N-[1-(1,3-benzodioxol-5-ylmethyl)piperidin-4-yl]-N-methylpyrimidin-2-amine
- 63979-60-2/N-[2-Hydroxy-1,1-bis(hydroxymethyl)ethyl]dodecanamide
- 19889-50-0/N-(2-bromo-4,5-dichlorophenyl)-2-chloroacetamide
- 25100-55-4/(4-iodobenzyl)propanedioic acid
- 70776-50-0/2-Propenoic acid, 2-methyl-, 2-hydroxyethyl ester, polymer with butyl 2-propenoate, methyl 2-methyl-2-propenoate, methyl 2-propenoate and 2-propenoic acid, compd. with 2-(dimethylamino)ethanol
- 5053-09-8/3-(1-methylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[3,4-b]azepine-1(2H)-carboximidamide
- 8066-49-7/1,5-dimethyl-2-phenyl-pyrazol-3-one; 2-hydroxypropane-1,2,3-tricarboxylate; 1,3,7-trimethylpurine-2,6-dione
- 33954-34-6/Thalrugosidine
- 164269-18-5/Pyrano[2,3-c]pyrrol-5(2H)-one,3,4,6,7-tetrahydro-3,4-dihydroxy-6-methoxy-7-methylene-2-[(1E,3E)-1,3-pentadienyl]-,(2S,3S,4S)- (9CI)
- 74037-47-1/2-(alpha-(beta-Dimethylaminoethoxy)-alpha-methyl-3,4-dimethylbenzyl)py ridine hydrochloride
- 74011-42-0/oxonorfloxacin
- 73840-54-7/N-Phenethyl-6-chloropyrimidine-4,5-diamine
- 125617-94-9/iralukast
- 52604-93-0/2-(2,5-dioxo-1-phenylpyrrolidin-3-yl)-1H-isoindole-1,3(2H)-dione
- 57342-06-0/2-Propen-1-one,1-(2-naphthalenyl)-3-(4- pyridinyl)-
- 144548-33-4/phenylalanyl-arginyl-valyl-phenylalanine
- 69779-92-6/palladium(2+) bis[(1-carboxy-2-hydroxyethyl)azanide]
- 83378-70-5/(+)-5-O-[2-O,3-O-[6-Amino-1,6-dideoxy-L-glycero-D-galacto-heptopyranose-1-ylidene]-β-D-manno-hexopyranosyl]-N'-methyl-2-deoxy-D-streptamine
- 74111-96-9/3-phenoxybenzyl (1S,3R)-3-[(1E)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate
- 103597-56-4/[(1R,2S,4R,5S)-2,3,4,6-tetrahydroxy-5-phosphonooxy-cyclohexyl]oxyphosphonic acid
- 142744-28-3/1,3-Benzenediamine,N1-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N3-(4-fluorophenyl)-4,6-dinitro-
- 85894-46-8/2',5-difluoro-1-arabinosyluridine monophosphate
- 4669-92-5/diethylantimony
- 116943-73-8/2-chloroethyl methyl[(1-phenylethyl)sulfamoyl]carbamate